Login

WANdisco's partnership with IBM uniquely enables the active replication of data across hybrid, cloud, and on-premises environments.|David Richards, CEO of WANdisco PLC 00:10:00

Share On Facebook Share On Twitter

David Richards, CEO of WANdisco PLC

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Mithril Resources: Unveiling Promising Gold Discoveries in Serbia
00:10:00
Anthony Smouha: Navigating Credit Opportunities in a Low Yield Environment
00:00:00
Facial Paralysis: What to Expect - Samir Mardini, M.D. Facial Plastic Surgeon, Mayo clinic
00:00:00
Chris Schaber, Soligenix Inc., talks about the collaborative efforts of the industry in response to COVID-19 - Christopher J. Schaber, PhD Chairman, President and Chief Executive Officer, Soligenix Inc
00:10:00
Unified Self-Service Platform: Book, Stay, Use & Pay |Gijs van Lookeren Campagne, CO-CEO of ease2pay nv
00:10:00
Lithium-ion Battery Industry Trends and Raw Material Impacts
00:10:00
Alderan Resources: Advancing High-Grade Copper and Gold Projects in Argentina
00:10:00
Navigating Economic Challenges: Insights from Dr. Peter R. Orszag | Peter Orszag - Chief Executive Officer at Lazard Asset Management
00:10:00
Assessing the Sustainability of Contour Global's Dividend - Ted Wainman | Financial Analyst and Trainer | Talk Financials
00:10:00
Foord Asset Management marks over 40 years in the market, with the team reflecting on lessons learned and achievements.
00:10:00
Azimut's Role in Empowering Italian SMEs and Savers | Paolo Martini, CEO , Azimut Holding.
00:10:00
VC that helps founders build defensible moats|Mike Zajko,Partner,Lattice

© 2017 - Neuhu+